V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280012117 | 280005181 | 1.8 | 83.6 | Palliative (P) | 2018-02-19 | 2018-02-27 | DOCETAXEL + GEMCITABINE | N | N | 280025794 | DOCETAXEL + GEMCITABINE |
| 280012118 | 280008757 | 1.59 | 73.2 | Palliative (P) | 2014-12-18 | 2015-02-12 | Carboplatin AUC 2 - 5 | 02 | N | 280025900 | CARBOPLATIN |
| 280012119 | 280008853 | 1.66 | 28.5 | Palliative (P) | 2015-07-05 | 2015-07-05 | Ifosfamide | 02 | N | 280026704 | IFOSFAMIDE |
| 280012120 | 280005439 | 1.76 | 64 | Palliative (P) | 2016-02-09 | 2016-02-22 | Cisplatin | 02 | N | 280026803 | CISPLATIN |
| 280012121 | 280005861 | 1.76 | 72.2 | Palliative (P) | 2017-09-04 | 2018-04-10 | Carboplatin + Etoposide IV 3 day | N | N | 280028302 | CARBOPLATIN + ETOPOSIDE |
| 280012122 | 280006000 | 1.66 | 84.7 | Palliative (P) | 2013-09-30 | 2016-11-25 | Carboplatin + Etoposide IV 3 day | 2 | N | 280028766 | CARBOPLATIN + ETOPOSIDE |
| 280012123 | 280006070 | null | 100.2 | Palliative (P) | 2018-07-18 | 2018-07-25 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 280029015 | GEMCITABINE |
| 280012124 | 280006353 | 1.78 | 66.4 | Palliative (P) | 2020-06-22 | 2020-09-02 | Dactinomycin + Vincristine | N | N | 280030055 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280012125 | 280006425 | 1.81 | 0 | Palliative (P) | null | 2014-09-15 | VINCRISTINE | 02 | null | 280030215 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280012126 | 280006443 | 1.61 | null | Curative (C) | 2019-10-19 | 2019-10-26 | Carboplatin + Cetux + FU (Cycle 1) | 02 | N | 280030268 | IRINOTECAN |
| 280012127 | 280006481 | 1.93 | 68.7 | Palliative (P) | 2018-08-16 | 2019-11-09 | Cisplatin + Fluorouracil + RT 5day | Y | N | 280030373 | CHOP R |
| 280012128 | 280009392 | 0 | 75.6 | Palliative (P) | 2014-11-23 | 2014-11-23 | Erlotinib | N | N | 280030483 | ETOPOSIDE |
| 280012129 | 280006672 | 1.83 | 68 | Palliative (P) | 2019-10-04 | 2019-10-12 | Rituximab | N | N | 280020669 | BUSULFAN + MELPHALAN |
| 280012130 | 280008739 | 1.69 | null | Disease modification (D) | 2018-05-22 | 2018-05-22 | Cisplatin + Radiotherapy | 02 | N | 280025794 | CISPLATIN + RT |
| 280012131 | 280008853 | null | 51.6 | Palliative (P) | 2015-07-11 | 2015-07-29 | Carboplatin AUC 2 - 5 | N | N | 280026704 | CARBOPLATIN |
| 280012132 | 280005440 | 1.56 | 12.7 | Palliative (P) | 2016-02-22 | 2016-02-22 | Ifosfamide | 02 | N | 280026803 | IFOSFAMIDE |
| 280012133 | 280005861 | 1.73 | null | Palliative (P) | 2018-05-31 | 2018-06-04 | Etoposide + Ifosfamide (5 days) | N | N | 280028302 | ETOPOSIDE + IFOSFAMIDE |
| 280012134 | 280009179 | 1.29 | 81 | Palliative (P) | 2018-07-12 | 2018-08-23 | Etoposide + Ifosfamide (3 days) | 02 | null | 280029015 | ETOPOSIDE + IFOSFAMIDE |
| 280012135 | 280009327 | 1.47 | 51.5 | Palliative (P) | 2020-10-08 | 2020-12-22 | Docetaxel 75mg/m2 (21 day) | N | N | 280030055 | MELPHALAN |
| 280012136 | 280006425 | 1.87 | 79.4 | Palliative (P) | null | 2014-10-27 | Capecitabine | 02 | null | 280030215 | CYCLOPHOSPHAMIDE + MTX |
| 280012137 | 280006443 | 1.68 | 65 | Neo-adjuvant (N) | 2019-10-26 | 2019-10-26 | Capecitabine | 02 | N | 280030268 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280012138 | 280006481 | 1.61 | 57.3 | Palliative (P) | 2018-11-19 | 2019-11-09 | NIVOLUMAB | N | N | 280030373 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280012139 | 280006672 | 1.6 | 56.8 | Palliative (P) | 2019-09-26 | 2019-10-12 | IDELALISIB | N | N | 280020669 | DOXORUBICIN + GEMCITABINE |
| 280012140 | 280008739 | 1.8 | null | Curative (C) | 2018-07-18 | 2018-07-24 | Cisplatin + Radiotherapy | 02 | N | 280025794 | CISPLATIN + RT |
| 280012141 | 280005440 | 0 | 27.6 | Not known (9) | 2016-03-28 | 2016-03-28 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280026803 | IVA |
| 280012142 | 280005861 | 1.61 | 0 | Palliative (P) | 2018-06-04 | 2018-06-04 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280028302 | CETUXIMAB + CISPLATIN + FU |
| 280012143 | 280009179 | 1.74 | 84 | Palliative (P) | 2017-06-25 | 2018-11-14 | GEMCITABINE | 02 | N | 280029015 | GEMCITABINE |
| 280012144 | 280006425 | 1.72 | 69.8 | Palliative (P) | null | 2016-05-24 | LANREOTIDE | 02 | N | 280030215 | BENDAMUSTINE + RITUXIMAB |
| 280012145 | 280006444 | 1.88 | 79 | Adjuvant (A) | 2020-01-23 | 2020-02-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL + RT | 02 | null | 280030268 | VIDE |
| 280012146 | 280005441 | 1.56 | 70.9 | Adjuvant (A) | 2016-04-03 | 2016-04-04 | Ifosfamide | 02 | N | 280026803 | IFOSFAMIDE |
| 280012147 | 280005862 | 1.87 | 64.45 | Adjuvant (A) | 2018-05-09 | 2018-06-04 | CARBOPLATIN + RT | N | Y | 280028302 | CARBOPLATIN + RT |
| 280012148 | 280009179 | 1.88 | 76 | Palliative (P) | 2018-12-04 | 2018-12-05 | Doxorubicin + Olaratumab | 02 | N | 280029015 | DOXORUBICIN + OLARATUMAB |
| 280012149 | 280006426 | 1.84 | 68 | Palliative (P) | null | 2016-05-24 | Cisplatin + Doxorubicin | 02 | N | 280030215 | NIVOLUMAB |
| 280012150 | 280005863 | 0 | 99.4 | Palliative (P) | 2018-06-21 | 2018-07-22 | null | 02 | N | 280028302 | NOT MATCHED |
| 280012151 | 280009179 | 1.63 | 74 | Palliative (P) | 2019-02-13 | 2019-03-13 | Etoposide IV | N | N | 280029015 | CARBOPLATIN + CETUXIMAB |
| 280012152 | 280009179 | 1.66 | 69.8 | Palliative (P) | 2019-01-21 | 2019-03-14 | Cisplatin + Fluorouracil + RT 5day | N | null | 280029015 | CARBO + FLUOROURACIL |
| 280012153 | 280009179 | 1.79 | 88.7 | Palliative (P) | null | 2019-08-14 | CYCLOPHOSPHAMIDE + MTX | N | null | 280029015 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280012154 | 280009179 | null | 130.6 | Palliative (P) | 2019-12-13 | 2019-12-14 | NB HRNBL-1 BUMEL MAT | N | null | 280029015 | NOT MATCHED |
| 280012155 | 280012107 | 1.61 | 84.5 | Palliative (P) | null | 2019-12-23 | CETUXIMAB + RT | N | null | 280029015 | CETUXIMAB + RT |
| 280012156 | 280012107 | 1.67 | 10.5 | Palliative (P) | 2018-08-29 | 2020-03-08 | Ifosfamide PVI 1g/m2 14day | N | N | 280029015 | IFOSFAMIDE |
| 280012157 | 280012136 | 1.67 | null | Curative (C) | 2020-01-27 | 2020-03-08 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 280029015 | CISPLATIN + RT |
| 290000001 | 290000001 | 1.7 | 86.2 | Curative (C) | 2017-01-12 | 2017-01-29 | FLUOROURACIL + MITOMYCIN + RT | 02 | null | 290000001 | FLUOROURACIL + MITOMYCIN + RT |
| 290000003 | 290000003 | 1.76 | 74 | Curative (C) | 2016-02-19 | 2016-03-09 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | 290000011 | FLUOROURACIL + MITOMYCIN + RT |
| 290000004 | 290000004 | 1.63 | 71.4 | null | null | 2015-01-25 | Fluorouracil+Mitomycin+RT (Anal Ca) | null | null | 290000016 | FLUOROURACIL + MITOMYCIN + RT |
| 290000005 | 290000005 | 1.65 | 81.5 | null | 2014-06-25 | 2014-06-25 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 290000017 | FLUOROURACIL + MITOMYCIN + RT |
| 290000006 | 290000006 | 1.6 | 73.6 | Curative (C) | 2017-06-29 | 2017-06-29 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | 290000018 | FLUOROURACIL + MITOMYCIN + RT |
| 290000007 | 290000007 | 1.73 | 88.7 | Adjuvant (A) | null | 2013-09-17 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | 290000021 | FLUOROURACIL + MITOMYCIN + RT |
| 290000008 | 290000008 | 1.63 | 81.2 | Curative (C) | 2015-05-12 | 2015-05-12 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | null | 290000026 | FLUOROURACIL + MITOMYCIN + RT |
| 290000009 | 290000009 | null | 68.45 | null | 2014-06-12 | 2014-06-27 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | 290000027 | FLUOROURACIL + MITOMYCIN + RT |
| 290000010 | 290000009 | 1.52 | 126 | Curative (C) | null | 2015-12-28 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | 290000027 | FLUOROURACIL + MITOMYCIN + RT |